Hitting a moving target
LA JOLLA, CA—May 14, 2014—A vaccine or other therapy directed at a single site on a surface protein of HIV could in principle neutralize nearly all strains of the virus—thanks to the diversity of targets the site presents to the human immune system. The finding, from a study led by scientists at The Scripps Research Institute (TSRI), is likely to influence future designs for HIV vaccines and antibody-based therapies. "We found, for example, that if the virus tries to escape from an antibody directed at that site by eliminating one of its sugars, the antibody often ...
Read the release








